Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252

Abroad (travel likely)RecruitingPHASE1

Conditions

Recurrent High Grade Glioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Memorial Sloan Kettering, New York, New York, United States
Contact: Study coordinator (Christian Grommes, MD) · grommesc@mskcc.org · 212-610-0344
Contact: Study coordinator (Lauren Schaff, MD) · schaffl@mskcc.org · 212-610-0485
Duke University, Durham, North Carolina, United States
Contact: Study coordinator (Mustafa Khasraw, MD) · mustafa.khasraw@duke.edu · 919-681-8838
Contact: Study coordinator (BTC Triage Help) · dukebrain1@duke.edu · 919-684-5301

View source on ClinicalTrials.gov Contact study team (email)